Studienzentrale GbR Lubecker Onkologische Schwerpunktpraxis

Site:	Studienzentrale GbR Lubecker Onkologische Schwerpunktpraxis
Address:
City:	Lubeck
State:
Zip:
Country:	Germany

Phase	Trial	Trial Status	Site Status	Drug	NCT#
3	(VOYAGER) Study of Avapritinib vs Regorafenib in Patients With Locally Advanced Unresectable or Metastatic GIST	Active, not recruiting	Active	Avapritinib or Regorafenib	NCT03465722